Mitochondrial CLPP In Health And Disease: Mechanisms, Therapeutic Duality And Emerging Opportunities
Our cells rely on tiny powerhouses called mitochondria to generate energy and keep everything running smoothly. Within these vital structures, a sophisticated quality control system ensures that proteins, the cell’s workhorses, are in good shape. A key player in this system is a protein known as CLPP, which acts like a cellular shredder, breaking down damaged or misfolded proteins to maintain mitochondrial health.
Interestingly, scientists have discovered that we can manipulate CLPP activity for therapeutic benefit, a concept referred to as “therapeutic duality.” In some situations, like certain bacterial infections, inhibiting CLPP can be advantageous by disrupting the bacteria’s ability to function.
Conversely, in diseases such as cancer, over-activating CLPP shows immense promise. Many cancer cells are highly dependent on their mitochondria for rapid growth. By dramatically increasing CLPP’s activity, we can cause an overload in the mitochondrial protein recycling system, leading to the breakdown of essential proteins and ultimately shutting down the cancer cell’s energy production. This catastrophic protein degradation can trigger cancer cell death. This strategy is already yielding results, with a drug that activates CLPP recently approved for a type of brain tumor, demonstrating the exciting potential of targeting this mitochondrial protein for novel treatments.
Source: link to paper